Pfizer, BioNTech Release Positive Topline Data for Combination COVID-19/Flu Vaccine
Drug Topics
OCTOBER 31, 2023
The combination vaccine produced robust immune responses from vaccine candidates in a phase 1/2 clinical trial.
Tue.Oct 31, 2023
502 
Roche’s $7B Roivant deal was a ‘moment of opportunity,’ CEO says
PharmaVoice
OCTOBER 31, 2023
Roivant CEO Matt Gline and Telavant CEO Frank Torti know Roivant’s position as buyers and sellers in the pharma industry, and they’re embracing those opportunities.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Addressing Challenges in Pediatric Tuberculosis Treatment
Drug Topics
OCTOBER 31, 2023
Pediatric TB is an intricate challenge that demands continued attention and funding.
Physical Activity Positively Impacts Symptoms of Depression, Anxiety
Pharmacy Times
OCTOBER 31, 2023
Modern society has put individuals at an increased risk of dopamine overload, causing an increase in mental health disorders.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Health Care Workers Can be Part of the Climate Change Solution
Drug Topics
OCTOBER 31, 2023
Anesthetic gases and meter dose inhalers, how we use our antibiotics, how we use our resources for infection prevention and control, and how we use plastic and food in our hospitals all add up.
STAT+: Tracking the FDA advisory panel on the first CRISPR-based treatment for sickle cell disease
STAT
OCTOBER 31, 2023
The Food and Drug Administration is convening a meeting of outside experts on Tuesday to review exa-cel, a CRISPR-based treatment for sickle cell disease made by Vertex Pharmaceuticals and CRISPR Therapeutics. Tuesday’s meeting is set up a bit differently than most FDA advisory panels. The agency has not raised any concerns about exa-cel’s efficacy or safety, and there will not be a typical vote at the end of the day on whether the data from exa-cel’s pivotal clinical trial
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Opinion: I lost my son to OxyContin. ‘The Fall of the House of Usher’ is my Sackler revenge fantasy
STAT
OCTOBER 31, 2023
Editor’s note: This essay contains spoilers for the Netflix show “The Fall of the House of Usher.” “W atch “ The Fall of the House of Usher” on Netflix when you can. F**cking Great! Totally based on the Sacklers—Fictional obviously but so damn good!
Assessing Impact of CGM on Progression of Coronary Atherosclerosis in Patients With T2D
Drug Topics
OCTOBER 31, 2023
The OPTIMAL trial assessed the effects of continuous glucose monitoring compared with HbA1c-guided glycemic control on the progression of coronary atherosclerosis in patients with type 2 diabetes mellitus.
STAT+: Eli Lilly to pay $200 million for Beam’s share of drugs from gene-editing firm Verve
STAT
OCTOBER 31, 2023
Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused on treatments for heart disease. The deal, which also includes future milestone payments, is evidence that despite the pressure on biotechnology stocks there is still interest in very early cutting-edge technologies among big pharmaceutical players.
FDA Approves sBLA for Abatacept in the Treatment of Juvenile Psoriatic Arthritis
Pharmacy Times
OCTOBER 31, 2023
The approval is supported by safety data from clinical trials assessing abatacept in the treatment of patients aged 2 to 17 with psoriatic arthritis.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: DeepMind touts AlphaFold’s new skills as protein-folding AI models face off
STAT
OCTOBER 31, 2023
On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology. Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, includin
Once a high-flying 'unicorn,' Olive AI sells two key businesses, winds down operations
Fierce Healthcare
OCTOBER 31, 2023
Healthcare startup Olive saw a meteoric rise in 2020 and 2021, spurred by the digital health funding boom and the need for automation during the COVID-19 pandemic. | It marks the end of the line for healthcare automation startup Olive AI. The company sold its clearinghouse and patient access business units to Waystar and its prior authorization business unit to Humata Health.
La ‘paradoja hispana’ intriga a una nueva generación de investigadores decididos a resolverla
STAT
OCTOBER 31, 2023
Read in English | Leer en inglés. D urante 40 años, los investigadores han intentado sin éxito explicar –o desacreditar– la “paradoja hispana”, es decir, la constatación de que los hispanoamericanos viven varios años más que los estadounidenses blancos por término medio, a pesar de disponer de ingresos y atención sanitaria mucho menores, y mayores tasas de diabetes y obesidad.
Review Treatment Options for Insomnia
Pharmacy Times
OCTOBER 31, 2023
According to 2020 data from the CDC, about 14.5% of adults reported having trouble falling asleep most or every day during the 30 days prior to the survey.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
How skeptical should you be of an after-the-fact subgroup analysis in a failed clinical trial?
STAT
OCTOBER 31, 2023
This article was adapted from STAT’s latest report , “Subgroup analysis: how to evaluate post hoc tests for significance in failed clinical trials.” C linical trials of newly developed drugs often don’t work out.
Nearly a quarter of hospital stent procedures are unnecessary, fueling billions in low-value spending, Lown Institute finds
Fierce Healthcare
OCTOBER 31, 2023
Nearly a quarter of hospital stent procedures are unnecessary, fueling billions in low-value spending, Lown Institute finds dmuoio Tue, 10/31/2023 - 14:33
New CDC campaign asks health care leaders to take responsibility for reducing burnout
STAT
OCTOBER 31, 2023
Often, workplace conversations about burnout put the onus on the individual to take care of their mental health while ignoring management’s role in solving the problem. A new anti-burnout campaign from the Centers for Disease Control and National Institute for Occupational Safety and Health avoids this typical — and often frustrating — tactic, instead imploring leaders to better support health care workers.
Wisp’s ‘bold and unapologetic approach’ to women’s sexual and reproductive health
PharmaVoice
OCTOBER 31, 2023
In the role of interim CEO of Wisp, Monica Cepak aims to break down barriers and expand access via telehealth.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Medicare is urged to consider Amgen patent maneuvers when negotiating the price for a drug
STAT
OCTOBER 31, 2023
As Medicare prepares to negotiate prices for its first batch of medicines, an advocacy group argues the agency should factor in controversial patent maneuvers for one drug that will have cost the program nearly $2 billion in additional spending by 2026. At issue is the Enbrel medication sold by Amgen for treating rheumatoid arthritis and other ailments.
Cleveland Clinic to launch prescription delivery via drone in 2025, starting with specialty and rush medications
Fierce Healthcare
OCTOBER 31, 2023
Cleveland Clinic plans to launch a drone delivery service to bring certain medications directly to patients’ homes, starting in 2025. | Cleveland Clinic plans to launch a drone delivery service to bring certain medications directly to patients’ homes, starting in 2025.
Rite Aid offers After Work Wednesday walk-in clinic
Drug Store News
OCTOBER 31, 2023
Customers and their families can conveniently get routine immunizations at select Rite Aid locations.
CDC releases free tools for hospitals to address their workers' mental health
Fierce Healthcare
OCTOBER 31, 2023
The Centers for Disease Control and Prevention (CDC) has launched the first-ever federal campaign encouraging hospitals to track and address burnout across their workforces. | Included among the Impact Wellbeing campaign’s free offerings are a wellbeing questionnaire, a leadership storytelling guide and a toolkit for removing mental health questions from a hospital's credentialing applications.
MHRA imposes restrictions on acne drug in children
pharmaphorum
OCTOBER 31, 2023
MHRA imposes restrictions on acne drug in children Phil.
Walmart celebrates re-grand opening of 117 remodeled stores
Drug Store News
OCTOBER 31, 2023
Walmart's largest single-day rollout of re-grand openings is part of more than 700 store modernizations expected in 2023.
Teamwork for Better Healthcare Solutions: Merging Clinical and Marketing Efforts
PharmExec
OCTOBER 31, 2023
In the ever-evolving landscape of healthcare, it's vital for organizations to take steps toward bridging the gap between their clinical and marketing teams.
Sarepta’s disappointing data put the FDA in a difficult spot
STAT
OCTOBER 31, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, all. Damian here with disappointing news on a closely watched gene therapy, an interesting deal in genome editing, and the long shadow of biotech’s slump.
Lilly buys Beam’s option on Verve drug programmes
pharmaphorum
OCTOBER 31, 2023
Lilly buys Beam’s option on Verve drug programmes Phil.
BJ’s Wholesale Club thanks members with free Thanksgiving turkeys
Drug Store News
OCTOBER 31, 2023
From Nov. 1–9, members will be eligible to receive a digital coupon for a free fresh or frozen Butterball whole turkey when they spend $150 in the same transaction, in-club or online.
Despite trial miss, Sarepta plans new filing for DMD therapy
pharmaphorum
OCTOBER 31, 2023
Despite trial miss, Sarepta plans new filing for DMD therapy Phil.
ArriVent’s lung cancer therapy gains FDA breakthrough therapy status
Pharmaceutical Technology
OCTOBER 31, 2023
ArriVent Biopharma has received the US FDA's breakthrough therapy designation for furmonertinib to treat non-small cell lung cancer.
After period of decline, dementia may be on the rise again
pharmaphorum
OCTOBER 31, 2023
After period of decline, dementia may be on the rise again Phil.
Open enrollment on the ACA exchanges is set to begin. Here are 5 trends to watch
Fierce Healthcare
OCTOBER 31, 2023
Open enrollment on the Affordable Care Act's (ACA's) exchanges is set to begin, but signing up for coverage remains confusing for many, a
La Roche-Posay’s 'Healing Power of Touch' campaign supports cancer patients, caregivers
Drug Store News
OCTOBER 31, 2023
In partnership with the Union for International Cancer Control, La Roche-Posay is launching a digital learning platform for cancer patients and caregivers.
Let's personalize your content